-
Most Popular
![Healthcare Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/healthcare-150x150.png)
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks](https://investorplace.com/wp-content/uploads/2024/06/dividend-stocks1600-5-150x150.png)
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
![medicine research, pharmaceutical background, LJPC stock](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-150x150.png)
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Why Is Onconetix (ONCO) Stock Up 37% Today?
Onconetix stock is up on Thursday with heavy trading of ONCO shares despite a lack of news from the biotechnology company.
3 Reliable Blue-Chip Stocks to Buy, Hold and Never Let Go
Load up your portfolio with the best blue-chip stocks to buy and hold and take home solid gains in the long-term.
3 Stocks You Haven’t Heard of That Could Be the Next Big Thing
These under-the-radar stocks have the potential to become the next big thing in their respective industries long-term.
7 Hated Stocks Set to Make a Major Comeback This Year
These seven out-of-favor stocks across various sectors have the potential to stage a significant rebound as market conditions improve.
3 Standout Stocks to Buy for the Next Bull Market
These standout stocks to buy for a bull market offer promising potential for significant gains as market conditions continue to strengthen.
3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition
These biotech stocks have promising outlooks that will bring major fortune to investors. Buy before it is too late.
AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buy
Ginkgo Bioworks has multiple, positive catalysts that can make the low valuation of Ginkgo Bioworks stock melt up.
Alnylam Stock Is a Blockbuster Biopharma In the Making
Alnylam stock could significantly pad its initial gains if vutrisiran gains expedited approval to hit the market.
Forget Boring Diversification! 3 Wild-Card Stocks to Spice Up Your Portfolio
These three wild-card stocks will spice up your portfolio in ways boring diversification never could, so read on.
7 High-Yield Dividend Stocks to Help Pay Your Bills
It’s time to stop actively generating wealth and let your money work for you with high-yield dividend stocks to buy.
SAVA Stock Plunges as Cassava Sciences CEO Steps Down. What to Know.
The CEO of Cassava Sciences is stepping down, effective immediately. Here's what this means for troubled SAVA stock.
3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition
Explore gene-editing stocks with potential to become multibaggers as the industry advances in treating genetic disorders.
LGVN Stock Alert: Longeveron Pops 18% on FDA Fast-Track Designation
Longeveron stock is up on Wednesday as LGVN investors react to Lomecel-B being granted fast-track designation by the FDA.
Why Is Aditxt (ADTX) Stock Up 72% Today!
Aditxt stock is up on Wednesday after ADTX investors learned of amended and restated merger plans with Evofem Biosciences this morning.
Stocks to Buy: 7 Founder-Led Companies Set to Outperform
These founder-led companies are at the forefront of industry innovation, and historical trends indicate that they will likely outperform.
3 Cannabis Stocks to Buy at a 52-Week Low in July
These cannabis stocks trading near 52-week lows have tremendous upside potential amid unique tailwinds and wider sector improvements.
3 Dividend Stocks With 3%+ Yields to Upgrade Your Annual Income
These high-yield dividend stocks will ensure steady quarterly income and help your money grow at little risk.
3 Top Cancer Treatment Stocks to Buy Now
These cancer treatment stocks are well-positioned to benefit tremendously from strong demand for their cancer treatments in the longer term.
7 Stocks to Buy in July 2024 and Hold Until You’re 70
These seven stocks offer a blend of stability and growth potential, making them ideal candidates for long-term investment strategies.